OTC Markets OTCPK - Delayed Quote USD

Itonis, Inc. (ITNS)

Compare
0.0005 0.0000 (0.00%)
At close: October 30 at 4:00 PM EDT
Loading Chart for ITNS
DELL
  • Previous Close 0.0004
  • Open 0.0004
  • Bid 0.0004 x --
  • Ask 0.0004 x --
  • Day's Range 0.0004 - 0.0004
  • 52 Week Range 0.0002 - 0.0013
  • Volume 100,000
  • Avg. Volume 911,852
  • Market Cap (intraday) 761,705
  • Beta (5Y Monthly) 0.07
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.

www.itonisholdings.com

3

Full Time Employees

November 30

Fiscal Year Ends

Recent News: ITNS

View More

Performance Overview: ITNS

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ITNS
25.00%
S&P 500
19.62%

1-Year Return

ITNS
25.00%
S&P 500
36.93%

3-Year Return

ITNS
82.14%
S&P 500
23.89%

5-Year Return

ITNS
50.00%
S&P 500
87.26%

Compare To: ITNS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ITNS

View More

Valuation Measures

Annual
As of 10/30/2024
  • Market Cap

    761.70k

  • Enterprise Value

    761.70k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.39M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    264

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ITNS

View More

Company Insights: ITNS

Research Reports: ITNS

View More

People Also Watch